Instituto Gulbenkian de Ciencia, Oeiras
Reducing pertussis transmission causes disease resurgence
Published in Pharma Investments, Ventures and Law Weekly, April 2nd, 2006
"Since the 1980s, the occurrence of pertussis cases in developed countries has increased and shifted towards older age groups. This resurgence follows 30 years of intense mass vaccination, and has been attributed primarily to three factors: more effective diagnosis of the disease, waning of vaccine-induced immunity, and loss of vaccine efficacy due to the emergence of new Bordetella pertussis strains. Here we develop and analyze a mathematical model to assess the plausibility of these hypotheses," investigators in Portugal report.
"We consider...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Acadia Pharmaceuticals, Inc.
Acadia Pharmaceuticals reports loss of $10.2M - Advaxis, Inc.
Fredrick D. Cobb appointed vice president of finance at Advaxis - Aksys, Ltd.
Aksys expects to report loss of $0.22 per share - Amgen
Amgen donates $1.1M to The Wellness Community - Amicas, Inc.
Amicas reports 17% increase in revenue - Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals reports revenues of $2M - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
